NEW YORK (GenomeWeb) – BioMérieux reported today that its third quarter revenues rose 6 percent from Q3 2016, including a 23 percent increase in molecular biology sales, and boosted by a period of fast-paced growth for the BioFire FilmArray product line both in the United States and in the rest of the world.  

For the quarter ended Sept. 30, the company reported total revenues of €540.0 million ($635.8 million), up from €510.8 million a year ago. Total revenues for the quarter at constant exchange rates and scope of consolidation rose 10 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.